Expression data from NSCs treated with REST inhibitor X5050
Ontology highlight
ABSTRACT: REST has been initially described as a repressor of neuronal genes in non-neuronal cells by binding to its recognition sequence RE1. Over-activation of this factor has been shown in several diseases such as Huntington disease or central nervous system cancers. High-throughput screening of a library of 6,984 compounds with luciferase-assay measuring REST activity in neural derivatives of human embryonic stem cells led to the identification of one benzoimidazole-5-carboxamide derivative (X5050) that inhibited REST silencing in a RE1-dependent manner. Differential transcriptomic analysis revealed the upregulation of neuronal genes targeted by REST.
ORGANISM(S): Homo sapiens
PROVIDER: GSE40695 | GEO | 2013/10/01
SECONDARY ACCESSION(S): PRJNA174634
REPOSITORIES: GEO
ACCESS DATA